Menu
Back to User profile » Dr Peng Xie
Papers published by Dr Peng Xie:
Diterpene Ginkgolides Exert an Antidepressant Effect Through the NT3-TrkA and Ras-MAPK Pathways
Wang T, Bai S, Wang W, Chen Z, Chen J, Liang Z, Qi X, Shen H, Xie P
Drug Design, Development and Therapy 2020, 14:1279-1294
Published Date: 31 March 2020
Commensal Microbiota Regulation of Metabolic Networks During Olfactory Dysfunction in Mice
Wang H, Liu L, Rao X, Chai T, Zeng B, Zhang X, Yu Y, Zhou C, Pu J, Zhou W, Li W, Zhang H, Wei H, Xie P
Neuropsychiatric Disease and Treatment 2020, 16:761-769
Published Date: 19 March 2020
Chronic Stress in a Rat Model of Depression Disturbs the Glutamine–Glutamate–GABA Cycle in the Striatum, Hippocampus, and Cerebellum
Xu S, Liu Y, Pu J, Gui S, Zhong X, Tian L, Song X, Qi X, Wang H, Xie P
Neuropsychiatric Disease and Treatment 2020, 16:557-570
Published Date: 24 February 2020
Alterations Of Glycerophospholipid And Fatty Acyl Metabolism In Multiple Brain Regions Of Schizophrenia Microbiota Recipient Mice
Liang W, Huang Y, Tan X, Wu J, Duan J, Zhang H, Yin B, Li Y, Zheng P, Wei H, Xie P
Neuropsychiatric Disease and Treatment 2019, 15:3219-3229
Published Date: 19 November 2019
Metabonomics reveals peripheral and central short-chain fatty acid and amino acid dysfunction in a naturally occurring depressive model of macaques
Deng F, Pan J, Zheng P, Xia J, Yin B, Liang W, Li Y, Wu J, Xu F, Wu Q, Qu C, Li W, Wang H, Xie P
Neuropsychiatric Disease and Treatment 2019, 15:1077-1088
Published Date: 1 May 2019
Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics
Hu Z, Fan S, Liu M, Zhong J, Cao D, Zheng P, Wang Y, Wei Y, Fang L, Xie P
Neuropsychiatric Disease and Treatment 2019, 15:867-881
Published Date: 10 April 2019
Activation of ERK/CREB/BDNF pathway involved in abnormal behavior of neonatally Borna virus-infected rats
Li C, Xu X, Zhang X, Cheng K, Guo Y, Jie J, Guo H, He Y, Zhou C, Gui S, Zhong X, Wang H, Xie P
Neuropsychiatric Disease and Treatment 2018, 14:3121-3132
Published Date: 15 November 2018
Modulatory interactions of resting-state brain functional connectivity in major depressive disorder
Tu Z, Jia YY, Wang T, Qu H, Pan JX, Jie J, Xu XY, Wang HY, Xie P
Neuropsychiatric Disease and Treatment 2018, 14:2461-2472
Published Date: 28 September 2018
Ginkgo biloba extract and its diterpene ginkgolide constituents ameliorate the metabolic disturbances caused by recombinant tissue plasminogen activator in rat prefrontal cortex
Chen Z, Bai S, Hu Q, Shen P, Wang T, Liang Z, Wang W, Qi X, Xie P
Neuropsychiatric Disease and Treatment 2018, 14:1755-1772
Published Date: 4 July 2018
Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics
Gui SW, Liu YY, Zhong XG, Liu XY, Zheng P, Pu JC, Zhou J, Chen JJ, Zhao LB, Liu LX, Xu GW, Xie P
Neuropsychiatric Disease and Treatment 2018, 14:1451-1461
Published Date: 6 June 2018
Metabolite-related antidepressant action of diterpene ginkgolides in the prefrontal cortex
Hu Q, Shen P, Bai S, Dong M, Liang Z, Chen Z, Wang W, Wang H, Gui S, Li P, Xie P
Neuropsychiatric Disease and Treatment 2018, 14:999-1011
Published Date: 13 April 2018
Sex differences in gut microbiota in patients with major depressive disorder
Chen JJ, Zheng P, Liu YY, Zhong XG, Wang HY, Guo YJ, Xie P
Neuropsychiatric Disease and Treatment 2018, 14:647-655
Published Date: 26 February 2018
Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies
Han Y, Chen J, Zou D, Zheng P, Li Q, Wang H, Li P, Zhou X, Zhang Y, Liu Y, Xie P
Neuropsychiatric Disease and Treatment 2016, 12:2859-2867
Published Date: 3 November 2016